Data Collective IV GP, LLC Long-Term Concentrated

CIK: 0001664974 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $93,837 (100.0% shares, 0.0% debt)

Holdings (6)

RXRX Recursion Pharmaceuticals, Inc. 42.2%

Value ($000) $39,627 Shares 5,941,120 Est. Cost $18.82 Unrealized -57.8%

EVLV Evolv Technologies Holdings, Inc. 35.2%

Value ($000) $33,076 Shares 10,601,281 Est. Cost $5.61 Unrealized -49.1%

— Rocket Lab USA, Inc. 12.6%

Value ($000) $11,835 Shares 2,929,350 Est. Cost $4.04 Unrealized —

— Embark Technology, Inc. 9.5%

Value ($000) $8,953 Shares 3,186,007 Est. Cost $7.43 Unrealized —

— Mind Medicine (MindMed) Inc. 0.3%

Value ($000) $318 Shares 100,350 Est. Cost $3.17 Unrealized —

ROIV Roivant Sciences Ltd. 0.0%

Value ($000) $29 Shares 3,875 Est. Cost $5.56 Unrealized +48.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RXRX	Recursion Pharmaceuticals, Inc.	5,941,120	$39,627	42.2%	$18.82	-57.8%	COM CL A	75629V104
EVLV	Evolv Technologies Holdings, Inc.	10,601,281	$33,076	35.2%	$5.61	-49.1%	COM CL A	30049H102
—	Rocket Lab USA, Inc.	2,929,350	$11,835	12.6%	$4.04	—	COM	773122106
—	Embark Technology, Inc.	3,186,007	$8,953	9.5%	$7.43	—	COM NEW	29079J202
—	Mind Medicine (MindMed) Inc.	100,350	$318	0.3%	$3.17	—	COM NEW	60255C885
ROIV	Roivant Sciences Ltd.	3,875	$29	0.0%	$5.56	+48.0%	SHS	G76279101